What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
Federico Garrido spends much of his time researching Human leukocyte antigen, Immunology, MHC class I, Major histocompatibility complex and Antigen.
His studies deal with areas such as Tumor Escape, Cytotoxic T cell, Molecular biology, Melanoma and Loss of heterozygosity as well as Human leukocyte antigen.
Federico Garrido combines subjects such as Cancer, Cancer research and Downregulation and upregulation with his study of Immunology.
His Cancer research study incorporates themes from Phenotype and Pathology.
Federico Garrido has included themes like Cell and MHC class II in his MHC class I study.
In his research, Gene expression is intimately related to Immunohistochemistry, which falls under the overarching field of Antigen.
His most cited work include:
- IMPLICATIONS FOR IMMUNOSURVEILLANCE OF ALTERED HLA CLASS I PHENOTYPES IN HUMAN TUMOURS (674 citations)
- Natural history of HLA expression during tumour development (401 citations)
- MHC class I antigens, immune surveillance, and tumor immune escape. (356 citations)
What are the main themes of his work throughout his whole career to date?
Human leukocyte antigen, Immunology, Antigen, Molecular biology and MHC class I are his primary areas of study.
His Human leukocyte antigen research is multidisciplinary, incorporating elements of Cancer, Immunotherapy, Cancer research, Loss of heterozygosity and Major histocompatibility complex.
His Immunology research includes themes of Phenotype and Cytotoxic T cell.
His research in Antigen tackles topics such as Monoclonal antibody which are related to areas like Immunohistochemistry.
Federico Garrido interconnects Cell culture, Cell, Gene expression, Gene and In vivo in the investigation of issues within Molecular biology.
The concepts of his MHC class I study are interwoven with issues in Cancer cell, Fibrosarcoma and Clone.
He most often published in these fields:
- Human leukocyte antigen (48.83%)
- Immunology (44.53%)
- Antigen (28.52%)
What were the highlights of his more recent work (between 2010-2021)?
- Human leukocyte antigen (48.83%)
- Cancer research (23.05%)
- Immune system (17.19%)
In recent papers he was focusing on the following fields of study:
Federico Garrido mostly deals with Human leukocyte antigen, Cancer research, Immune system, Immunology and Immunotherapy.
Human leukocyte antigen is the subject of his research, which falls under Antigen.
His biological study spans a wide range of topics, including Bladder cancer, Cytotoxic T cell, MHC class I, Major histocompatibility complex and Disease.
The various areas that Federico Garrido examines in his Immune system study include Cancer, Tumor progression and Cancer dormancy.
His study in Immunology is interdisciplinary in nature, drawing from both Viral vector and Gene.
His work in the fields of Immunotherapy, such as Cancer immunotherapy, overlaps with other areas such as Context.
Between 2010 and 2021, his most popular works were:
- The urgent need to recover MHC class I in cancers for effective immunotherapy. (282 citations)
- Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors (192 citations)
- Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma. (87 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
His primary areas of investigation include Human leukocyte antigen, Immunology, Immune system, MHC class I and Immunotherapy.
His research in Human leukocyte antigen intersects with topics in T cell, Antigen presentation, Cancer immunotherapy, Melanoma and Loss of heterozygosity.
Federico Garrido has researched Immunology in several fields, including Cancer and Cytotoxic T cell.
His Immune system research incorporates themes from Stromal cell and Infiltration.
MHC class I is a subfield of Major histocompatibility complex that Federico Garrido tackles.
His studies in Immunotherapy integrate themes in fields like Immunohistochemistry, Urinary bladder and MHC class I antigen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
